Assessment Tools |
Pediatric Early Warning Systems (PEWS) |
Behavioral, Growth and Development |
Attention-Deficit Hyperactivity Disorder (ADHD): Screening and Diagnosis |
Behavioral, Growth and Development |
Autism Spectrum Disorder: Screening and Diagnosis |
Cardiovascular |
Kawasaki Disease: Diagnosis and Management |
Cardiovascular, Hematological |
Vascular Thrombosis: Arterial Thrombosis |
Cardiovascular, Hematological |
Vascular Thrombosis: Venous Thrombosis |
Cardiovascular, Nervous |
Acute Ischemic Stroke |
Cardiovascular |
Heart Failure, Acute Decompensated |
Digestive, Infection |
Gastroenteritis (Acute Vomiting and/or Diarrhea) |
Endocrine |
Diabetes: Continuous Glucose Monitoring in Type 1 Diabetes Mellitus |
Endocrine |
Diabetes: Diabetic Ketoacidosis (DKA) |
Endocrine |
Diabetes: Hyperglycemic Hyperosmolar State [with or without DKA] |
Endocrine |
Diabetes: Perioperative Management |
Endocrine, Growth and Development |
Overweight and Obesity |
Endocrine, Perioperative |
Thyroid Carcinoma (Well-Differentiated): Perioperative Management |
Genitourinary, Infection |
Urinary Tract Infection, First Febrile |
Growth and Development |
Malnutrition (formerly Failure to Thrive) |
Hematological, Perioperative |
Red Blood Cell Transfusions |
Hematological, Perioperative |
ROTEM-Guided Goal-Directed Therapy for Bleeding After Cardiopulmonary Bypass in Pediatric Heart Surgery |
Hematological |
Sickle Cell Disease Management of Acute and Chronic Pain |
Hematological |
Sickle Cell Disease and Acute Chest Syndrome |
Hematological |
Sickle Cell Disease With Fever |
Infection |
Diagnosis and Management of Suspected Central Line-Associated Bloodstream Infections (CLABSI) |
Infection |
Central Line-Associated Bloodstream Infection (CLABSI) Prevention Guideline |
Infection |
Care of the Hospitalized Patient with COVID-19 |
Infection |
Fever and Neutropenia in Children Receiving Cancer Treatment or with Blood Disorders |
Infection |
Fever Without Localizing Signs, 0-60 Days |
Infection |
Fever Without Localizing Signs, 2-36 Months |
Infection |
Infection Prevention in the Pediatric Patient with Neutropenia |
Infection, Musculoskeletal and Integumentary |
Osteomyelitis, Acute Hematogenous (AHO) and/or Septic Arthritis |
Infection |
Septic Shock: Recognition and Initial Management |
Infection |
Skin and Soft Tissue Infection/Abscess |
Infection, Respiratory |
Management of Respiratory Symptoms and Possible Infectious Complications in Patients with an Artificial Airway |
Medications |
Ketamine Subanesthetic Intravenous Infusions for Analgesia |
Medications, Neonatal, Respiratory |
Palivizumab (Synagis) Prophylaxis in Hospitalized Patients |
Medications |
Procedural Sedation |
Musculoskeletal and Integumentary |
Management of Acute and Chronic Wounds |
Musculoskeletal and Integumentary, Perioperative |
Spinal Instrumentation: Intraoperative Infection Prevention |
Neonatal |
Hyperbilirubinemia |
Nervous |
Migraine Headaches: Treatment in the EC |
Nervous |
Status Epilepticus: Initial Management |
Nervous, Trauma |
Closed Head Injury: Initial Assessment in the Emergency Center |
Nervous, Trauma |
Evaluation and Management of Pediatric Concussion |
Nervous, Trauma |
Traumatic Brain Injury, Severe |
Perioperative |
Acute Appendicitis/Appendectomy |
Perioperative |
Bromage Scale: Assessment of Leg Weakness After Epidural Analgesia |
Perioperative |
Craniosynostosis (Primary Repair): Preoperative Management of Patients |
Perioperative |
Mediastinal Mass (Anterior): Perioperative Management |
Perioperative, Respiratory |
Pneumothorax, Primary Spontaneous |
Perioperative |
Tonsillectomy & Adenoidectomy: Perioperative Medical Management |
Respiratory |
Asthma: Acute Exacerbations |
Respiratory |
Asthma: Chronic Management |
Respiratory, Neonatal |
Brief Resolved Unexplained Event |
Respiratory |
Bronchiolitis |
Respiratory |
Croup |
Respiratory, Infection |
Community-Acquired Pneumonia |
Respiratory |
High Flow Nasal Cannula Therapy: Initiation and Escalation for Respiratory Distress |
Respiratory |
Oxygen Weaning Protocol |